Effect of Angiotensin II on Blood Flow in Acute and Chronically Inflamed Knee Joints of Rabbits: The Role of Nitric Oxide

Najafipour, Hamid; Nikbakht, Farnaz; Sadeghi, Najmeh; Dehghani, Gholam Abbas
March 2009
Iranian Journal of Medical Sciences;Mar2009, Vol. 34 Issue 1, p36
Academic Journal
Background: Angiotensin converting enzyme (ACE) upregulation in stromal cells of joints affected by rheumatoid arthritis may lead to higher tissue angiotensin II that is a vasoconstrictor and mitogen factor. To date, the role of angiotensin II on regulating blood flow in inflamed joints has not been studied. Methods: Acute and chronic joint inflammation was induced in rabbits by intra-articular injection of carrageenan and antigen- induced arthritis method, respectively. The ACE level of synovial fluid and the response of joint blood flow to angiotensin II, angiotensin II receptor antagonist, and the role of nitric oxide (NO) in modulation of the effects of angiotensin II on joint blood vessels were examined. Results: The synovial fluid level of ACE was significantly increased during the process of inflammation and angiotensin II increased joint vascular resistance dose-dependently in both acute and chronically inflamed joints. The angiotensin 1 receptor antagonist losartan completely blocked the vasoconstrictor effect of angiotensin II on joint blood vessels and induced vasodilatation. Nitric oxide synthase inhibitor N-omega -nitro L- arginine methyl ester (L-NAME) increased joint vascular resistance and augmented vascular response of inflamed joints to angiotensin II. Conclusion: Angiotensin II receptors in joint blood vessels are angiotensin -1 subtype, and inflammation significantly increases the activity of synovial fluid ACE. Nitric oxide plays a significant role on regulating joint blood flow and in modulation of angiotensin 1 receptor-mediated vasoconstriction of inflamed joint blood vessels.


Related Articles

  • The kallikrein-kinin system in diabetic nephropathy. Tomita, Hirofumi; Sanford, Ryan B; Smithies, Oliver; Kakoki, Masao // Kidney International;Apr2012, Vol. 81 Issue 8, p733 

    Diabetic nephropathy is the major cause of end-stage renal disease worldwide. Although the renin-angiotensin system has been implicated in the pathogenesis of diabetic nephropathy, angiotensin I-converting enzyme inhibitors have a beneficial effect on diabetic nephropathy independently of their...

  • Effect of long-term treatment with urocortin on the activity of somatic angiotensin-converting enzyme in spontaneously hypertensive rats. Cui Yang; Xiuxia Liu; Shengnan Li // Canadian Journal of Physiology & Pharmacology;Feb2010, Vol. 88 Issue 2, p168 

    Our previous acute study on urocortin (Ucn) demonstrated that Ucn altered serum and tissue angiotensin-converting enzyme (ACE) activity in rats. Therefore, the present investigation was designed to explore the effect of long-term treatment with Ucn on somatic ACE (sACE) and other components of...

  • Prescription Data Related to the Use of Calcium Channel Blockers, ACE Inhibitors and Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) in Combination Identify Savings Opportunities. Carugo, Stefano; Rossetti, Giuseppe; Merlino, Luca; Mancia, Giuseppe // High Blood Pressure & Cardiovascular Prevention;Mar2009, Vol. 16 Issue 1, p21 

    Background: It is now recognized that treating hypertension with combination therapy is required to achieve target blood pressure in the majority of patients. Objective: To investigate the use of ACE inhibitors, angiotensin II type 1 receptor antagonists (angiotensin receptor blockers [ARBs])...

  • ACEI/ARB therapy for aortic stenosis. Elliott, William T. // Neurology Alert;Sep2011 Supplement, p1 

    The article discusses a study which suggests that therapy using angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) improve the survival of patients with aortic stenosis (AS) and lower the risk of cardiovascular (CV) deaths.

  • Highlights.  // American Journal of Hypertension;May2011, Vol. 24 Issue 5, p503 

    The article offers information on the research studies related to the therapeutic efficacy of angiotensins in patients with hypertension and early onset-diabetes. A randomized meta-analysis study of renin inhibitor aliskiren and angiotensin receptor blocker (ARB) in blood pressure is presented....

  • ONTARGET: Is an ARB. as good as an ACE? Lindsay, Alistair C.; Qureshi, Katie // Heart;Aug2008, Vol. 94 Issue 8, p1102 

    The article offers information on Ongoing Telmisartan Alone and in Combination with Ramipril Global End-point Trial (ONTARGET), a comparative study between angiotensin II receptor blockers (ARBs) and angiotensin converting enzyme (ACE) inhibitors. It demonstrates that telmisartan preserved the...

  • Correction.  // American Family Physician;12/15/2012, Vol. 86 Issue 12, p1096 

    A correction to an article about the effectiveness of ACE inhibitors and angiotensin II receptor blockers that was published in the July 15, 2012 issue of "The Clinical Evidence Handbook" is presented.

  • Two ACEs and a heart. Bernstein, Kenneth E. // Nature;6/20/2002, Vol. 417 Issue 6891, p799 

    Comments on an article by M.A. Crackower and colleagues on the cardiac function of angiotensin-converting enzyme (ACE) 2. Physiology of the peptide angiotensin II; Importance of angiotensin II; Discovery of ACE2.

  • New Strategies and Drugs in the Treatment of Hypertension: Monotherapy or Combination? Destro, Maurizio; Cagnoni, Francesca; D'Ospina, Antonio; Ricci, Alessandra R.; Zaninelli, Augusto; Preti, Paola // Recent Patents on Cardiovascular Drug Discovery;Jan2010, Vol. 5 Issue 1, p69 

    Hypertension is one of the major risk factors associated with cardiovascular diseases. A range of blood pressure-lowering agents is available including diuretics, a and �-blockers, aldosterone antagonists, calcium-channel blockers, angiotensin-converting enzyme inhibitors, angiotensin II...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics